Ten minutes of complete cerebral ischemia was produced in 26 dogs by temporary ligation of the aorta and the venae cavae. Twenty dogs received nimo dipine, a calcium entry blocker, 10 f,1g kg-I i. v. 2 min after the ischemic period, followed by 1 f,1g kg-1 min -I for 2-3 h. Six dogs received only the solvent used for nimodi pine. Fourteen dogs received nimodipine for 3 h and were subsequently evaluated neurologically up to 48 h post ischemia. In the 12 other dogs, CBF and metabolism were followed for 2 h postischemia while either nimodipine or the solvent only was infused. The results were compared to previously published results for untreated dogs and dogs given nimodipine before the ischemic event. Ni modi pine had the same effect on postischemic CBF whether started before or after the ischemic event, nearly doubling the flow when compared with untreated con-
Recently there has been interest in the role of calcium in ischemic brain injury and, therefore, in the possibility of protective effects of various cal cium entry blockers (Siesj6, 1981; Harris et a!., 1982; White et a!., 1982; Wielock et aI., 1982) . Be cause calcium is involved in the contraction of vas cular smooth muscle (Bolton, 1979) , it is speculated that calcium may produce the increase in cerebro vascular resistance (CVR) that is known to occur after a period of complete cerebral ischemia (Hossmann et aI., 1973; Snyder et aI., 1975; Steen et aI., 1978 Steen et aI., , 1983 . Calcium might also be involved in other deleterious reactions occurring intracellularly in the brain, including membrane phospholipid trois, whereas the solvent alone caused only a slight in crease in CBF over control. By contrast, nimodipine ini tiated in the preischemic period significantly improved the neurologic outcome, but when initiated in the post ischemic period the results were equivocal, such that the outcome was not significantly different from either the untreated group or the group in which nimodipine was initiated preischemia. Metabolic measurements did not give any indication of a specific effect of nimodipine, nor could the metabolic results be used as an indicator of neurologic outcome. The results are consistent with a beneficial effect of nimodipine following complete cere bral ischemia; however, evaluation of neurologic func tional effects will require a more sensitive model. Key Words: Calcium entry blocker-Cerebral protection Complete cerebral ischemia-Nimodipine.
breakdown (Schanne, 1979; Hass, 1981; Siesj6, 1981; White et aI., 1982) . It is therefore speculated that calcium entry blockers might prevent the in crease in CVR or membrane phospholipid break down which occurs after an ischemic event.
We had reported previously that infusion of the calcium entry blocker nimodipine, initiated before 10 min of complete cerebral ischemia in dogs, im proved both the postischemic CBF and the neuro logic outcome, compared with untreated controls (Steen et al., 1983) . However, to be clinically useful, such treatment must be shown to be effec tive when initiated only after the ischemic period. We therefore performed a second series of experi ments studying CBF, metabolism, and neurologic outcome in our model of complete cerebral isch emia in which we administered nimodipine only after the ischemic event (posttreated group). These results were compared with the previous results (Steen et a!., 1983) for dogs not given any drug (un treated group) and dogs given nimodipine both pre-and postischemia (pretreated group). In addition, we examined the effects of the solvent for nimodi pine on CBF and metabolism (solvent group).
MATERIALS AND METHODS
Twenty-six unmedicated, fasting adult mongrel dogs weighing 9.5-19.5 kg were studied in the prone position. CBF and cerebral metabolic rate for oxygen (CMRO,) were studied in six dogs given nimodipine (posttreated group), which was initiated after 10 min of complete ce rebral ischemia. Six other dogs were studied similarly, but were given only the solvent used for nimodipine (sol vent group). (Each 10 ml of solvent contained 1.5 g ethanol, 1.5 g polyethylene glycol 400, 0.02 g sodium ci trate, 0.003 g citric acid, and 7 g water.) In 14 dogs also treated with nimodipine initiated after 10 min of complete cerebral ischemia, neurologic function was evaluated for 48 h postischemia. All results were compared with those previously published (Steen et aI., 1983) for untreated controls (untreated group) and dogs given nimodipine both before and after an identical ischemic event (pre treated group).
In the 12 dogs used to study CBF and CMR02, anes thesia was induced and maintained throughout the sur gical procedure with 1 % halothane in 60-70% nitrous oxide and oxygen. Succinylcholine, 2 mg kg -I, was given i. v. to facilitate endotracheal intubation, and thereafter was continuously infused (7.5 mg kg-I h -I) to maintain muscle paralysis. Ventilation was controlled with a Har vard pump and, after initial adjustment to maintain PaCOZ close to 38 mm Hg, was kept constant. Cannulae were inserted into a femoral artery for blood sampling and con tinuous monitoring and intermittent recording of arterial pressure, and into a femoral vein for drug and fluid ad ministration. Through a right-sided thoracotomy in the fourth intercostal space, umbilical tapes were placed around the ascending aorta, inferior vena cava, and su perior vena cava above the azygos vein. After heparin ization (300-400 U kg-I i.v.) the sagittal sinus was ex posed, isolated, and cannulated as previously described for direct measurements of CBF from anterior, superior, and lateral portions of both hemispheres (equal to �54% of the total brain weight) (Michenfelder et aI., 1968) . A four-lead bilateral electroencephalogram (EEG) was ob tained from electrodes glued to the skull. Body temper ature was measured with an esophageal thermistor and brain temperature with a parietal epidural thermistor, both maintained at 37.0 + O.I°C by the use of heat lamps as needed. PaOZ, PaCOZ' pH, and sagittal sinus P02 (Pssoz) were determined by electrodes (Instrumentation Labo ratories) at 37°C. Blood oxygen contents were calculated from measurements of oxyhemoglobin concentrations (IL 282 CO oximeter) and O2 tensions. CMR02 was calcu lated as the product of CBF and arterial-sagittal sinus blood O2 content differences. The surgical procedure re quired 20-30 min; thereafter, halothane was discontinued for at least 20 min before obtaining preischemic measure ments of CBF and CMR02. Complete cerebral ischemia lasting exactly 10 min was achieved by a previously de scribed method (Steen et aI., 1978) . The umbilical tapes placed around the ascending aorta and inferior and su perior venae cavae were simultaneously occluded, con fining cardiac output to corouary and pulmonary circu lation. The sagittal sinus cannula was also occluded during this time to avoid aspiration of air. In all dogs the EEG became isoelectric within 45 s of occlusion. There after, nitrogen was substituted for nitrous oxide in the inspired gas for the rest of the study. After 10 min, the tape around the aorta was released, the tapes around the venae cavae having been released 15-20 s earlier.
Two minutes after release, six dogs were given a bolus of nimodipine (10 fLg kg -l) followed by a I fLg kg -1 min -1 infusion for 2 h. The volume infused was 17.1 ml h -1 for all dogs because of dilution with normal saline. Six other dogs were given the solvent only as a bolus of 0.1 ml kg-I followed by an infusion at 17.1 ml h -I. CBF and CMR02 were measured during a l20-min period postischemia; thereafter, the dura overlying the cerebral hemispheres was excised, and cortical biopsies were taken by a tech nique that deposits a sample of brain (200-400 mg) into liquid nitrogen within 1 s (Kramer et aI., 1968). The tissue was stored at -76°C and prepared for analysis in a re frigerated box (-25°C), as described by Folbergrova et al. (1972) . Tissue extracts were analyzed by enzymatic fluorometric techniques for phosphocreatine (P Cr), ATP, ADP, AMP, glucose (Lowry and Passonneau, 1972) , and lactate and pyruvate (Lowry et aI., 1964) . The sum of the adenine nucleotides (Ad) was calculated as � Ad = [ATP] + [ADP] + [AMP], and the energy state of the tissues was expressed as the energy charge (EC) = ([ATP] + 0.5 [ADP])/�[Ad] (Atkinson, 1968) .
In the 14 dogs used for neurologic functional studies, anesthesia was induced and maintained with 70% nitrous oxide and oxygen. The inspired gas was changed to 100% oxygen 5 min preischemia and to room air 20 min post ischemia. Intubation, ventilation, femoral venous and arterial cannulations, and thoracotomy were per formed as in the previous group, but 20 ml 0.5% procaine was infiltrated into the chest wall before the thoracotomy, and succinylcholine was given only to facilitate intubation (2 mg/kg). In these dogs, a four-lead EEG was recorded with needle electrodes. Body temperature was main tained at 37 -38°C by the use of heat lamps and electri cally heated blankets as needed. Nimodipine, 10 fLg kg-I, was given 2 min after ischemia followed by an infusion of 1 fLg kg-I min-I for 180 min. After the ischemic epi sode, the thoracotomy was closed. Arterial blood gases were measured before ischemia and at regular intervals afterwards. Ventilation was controlled until spontaneous ventilation was deemed adequate (PacoZ < 45 mm Hg). The dogs were then extubated and observed. Forty-eight hours postischemia, the dogs were evaluated neurqlogi cally and assigned to one of four groups. Grade I (no damage) dogs ate and behaved normally and their move ments were fully coordinated. Grade 2 (moderate damage) dogs could stand alone, but were ataxic or ex hibited partial or complete blindness. Grade 3 (severe damage) dogs could not stand alone or were comatose. Grade 4 dogs died within 48 h. The surviving dogs were killed after 48 h, and at necropsy the thorax was exam ined in all dogs to assess any gross post-thoracotomy complications.
For statistical comparison of the neurologic outcome between dogs in the present study and previously pub lished groups (Steen et aI., 1983) , the Fisher exact test was used.
Since previous studies (Steen et aI., 1978 (Steen et aI., , 1983 had indicated that the delayed hypoperfusion period started �20 min postischemia, CBF and CMR02 values were compared by a paired Bonferroni t test (Glantz, 1981) , using the mean CBF and CMR02 values for the different groups at each measurement period from 20 to 120 min postischemia.
For other comparisons between the groups, analysis of variance was used followed by a Bonferroni t test to iso late the difference between groups. A p value of less than 0.05 was regarded as statistically significant (requiring p < 0.008 in the Bonferroni t test for four groups with six possible comparisons).
RESULTS

CBF and metabolic studies
There were no significant differences between untreated, solvent, nimodipine-pretreated, and ni modipine-posttreated groups in pressures or blood gases preischemia (Table 1) . Postischemia, mean ar terial pressure (MAP) was higher in the untreated group than in the others. This group also had a higher Ppz and Pssoz 1 min postischemia. At 90 min postischemia there was a significantly greater Ps p z in the posttreated group and a higher pH in the pre treated group. There were no other significant dif ferences in blood gases between the groups. In all groups P aCoZ was significantly increased, and pH decreased at 1 min postischemia, due to the accu mulation of both COz and lactate during the isch emic period. COz was normalized in all groups within 10 min postischemia.
There was no significant differences in CBF be tween the groups preischemia ( Figs. 1 and 2) . CBF increased in all groups during the first 10 min post ischemia ( Fig. 1) (Steen et ai., 1978) , followed by a gradual decline, and then stayed significantly below control in all groups starting 20 min post-ischemia (25 min postischemia in the pretreated group). For the remainder of the study, CBF stayed significantly higher in the two groups given nimo dipine than in the untreated or solvent groups. Whether nimodipine was started before or after the ischemic event had no significant effect. CBF in the solvent group was intermediate, significantly less than CBF in the two nimodipine groups but greater than CBF in the untreated group (Fig. 2 ). There were no significant differences in CMROz between the groups preischemia ( Figs. 3 and 4) . After 20 min postischemia, CMROz in the untreated group stayed significantly lower than in the other three groups. CMROz in the pretreated group was signif icantly lower than in the posttreated or solvent groups.
In all groups the EEG became isoelectric within 14-15 s of circulatory arrest. There was return of electrical activity 17-19 min following restoration of the circulation.
There were no significant differences in cerebral metabolite levels among the four groups (Table 2) .
Neurologic studies
We previously reported (Steen et aI., 1983) that the pretreated nimodipine group had significantly better neurologic function 48 h postischemia than did the untreated group (Table 3 ). In the current study, when nimodipine was given only post ischemia, neurologic function at 48 h was interme diate and not significantly different from either the untreated or pretreated group. The differences in results cannot be accounted for by any differences in vascular pressures or blood gases either pre-or postischemia (Table 4 ). 
DISCUSSION
It has been suggested that the neurologic damage which occurs subsequent to a period of complete cerebral ischemia is due at least in part to a delayed hypoperfusion state following reperfusion (Siesjo, Steen et al. (1978) , for which the postischemic biopsies were taken after 90 min. In the same study, other biopsies were taken after 180 and 360 min, showing no change in EC, glucose, or lactate/pyruvate, whereas PCr and ATP levels tended to increase gradually with time. Thus, it should be appropriate to compare the 90-min values from the previous study with present biopsies taken 120 min postischemia. There are no significant differences between the groups. PCr, phosphocreatine; EC, energy charge.
1978; White et al., 1982) . This is consistent with our previous finding that the neurologic outcome in dogs treated with nimodipine was improved, as was the postischemic hypoperfusion state (Steen et al., 1983) . Similar results with nimodipine have been reported in cats by Hoffmeister et al. (1982) and Kazda et al. (1982) (studies generated in the man ufacturer's laboratory).
In the above-mentioned studies, nimodipine treatment was initiated before the ischemic event. Accordingly, the reported beneficial effect of ni modi pine may have been limited to an effect that was operative during the period of complete isch emia only. It has been suggested that calcium may have a direct deleterious effect on brain cells by stimulating phospholipase activity with release of free fatty acids such as arachidonic acid (Schanne, 1979; Hass, 1981; Siesj6, 1981; White et al., 1982) . Hass (1981) has suggested that increased intracel lular calcium may also cause damage by stimulating the turnover of the phosphotidylinositol cycle af fecting neurotransmitter metabolism. Thus, the presence of a calcium entry blocker during the pe riod of complete ischemia might produce a benefi cial effect unrelated to any effect on postischemic perfusion. In support of this, Poole-Wilson (1980) , in a study of myocardial ischemia, has reported a difference in the effect of the calcium entry blocker verapamil when given before or after the start of the ischemic event.
We therefore studied nimodipine when given only postischemia for two reasons. First, if nimodipine improved neurologic outcome in this situation, it would more strongly support a recommendation for clinical application, since most periods of complete cerebral ischemia cannot be foretold and only post ischemic treatment is possible, Second, if post ischemic nimodipine treatment had the same effect on CBF as preischemic treatment, but without af fecting the outcome, this would indicate that the delayed hypoperfusion state does not contribute to neurologic outcome, and that other beneficial ef fects of nimodipine, as suggested above, must be operative.
The present results indicate that nimodipine need not be given preischemia to improve postischemic perfusion. This seems to be an effect primarily of nimodipine, although its solvent may also con tribute to the increase of CBF. By contrast, nimo dipine treatment had no effect on cerebral metab olite levels, which again supports the conclusion that such measurements are not sensitive indicators of neurologic function (Mrsulja et al., 1976; Levy and Duff, 1977) .
Unfortunately, the results of the neurologic study neither supported nor refuted the hypothesis that an increase in postischemic CBF would improve neurologic outcome, Whereas the pretreated group had a significantly better outcome than the un treated group, the results for the posttreated dogs were numerically intermediate and not statistically different from either of the other two groups. This uncertainty possibly could have been resolved by increasing the number of experiments, but calcu lations revealed that a significant difference would require more than 36 additional experiments. Fur thermore, it would not be acceptable statistically to simply increase the number of experiments until the posttreated group became significantly different from either of the other two groups. That would require a completely new experimental design (Glantz, 1981) . Thus the importance of the delayed hypoperfusion state and the possible clinical ben efits of calcium entry blocker therapy following complete cerebral ischemia must still be considered unresolved. Further studies in more sensitive an imal models are warranted before human studies can be justified. This is especially important since Harris et al. (1982) recently reported that nimodi pine might have potential deleterious effects on ischemic brain.
In conclusion, nimodipine treatment initiated after complete cerebral ischemia increases CBF in the postischemic hypoperfusion period and appears to be as effective as an infusion initiated preisch emia. The latter treatment also improves neurologic outcome, whereas the neurologic outcome fol lowing treatment initiated postischemia was equiv ocal. Additional studies in a more sensitive animal model are needed.
